Penserra Capital Management LLC Scholar Rock Holding Corp Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$24.14 - $35.18 $19,070 - $27,792	-790 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.38 - $42.21 $136 - $211	5 Added 0.64%	790 $26,000
Q2 2021 Aug 12, 2021	BUY	$26.34 - $46.62 $526 - $932	20 Added 2.61%	785 $22,000
Q1 2021 May 13, 2021	SELL	$45.96 - $68.02 $229 - $340	-5 Reduced 0.65%	765 $38,000
Q4 2020 Feb 12, 2021	BUY	$13.72 - $51.57 $7,052 - $26,506	514 Added 200.78%	770 $37,000
Q3 2020 Nov 13, 2020	BUY	$10.54 - $18.47 $2,698 - $4,728	256 New	256 $4,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.